# X4 Pharmaceuticals, Inc: Form DEF 14A, filed Mar 24, 2025

- Company: [X4 Pharmaceuticals, Inc](/companies/xfor.md) (CIK 1501697)
- Form: DEF 14A
- Filed: 2025-03-24
- Accepted by EDGAR: Mar 24, 2025, 16:43 ET
- Period: 2025-03-24
- Accession: 0001628280-25-014535
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1501697/000162828025014535/a2025def14aspecialmeetingu.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501697/000162828025014535/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501697/000162828025014535/a2025def14aspecialmeetingu.htm

Filed Mar 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-014535. Last ingested by Listed: Oct 29, 2026, 10:01 ET. No prices; not investment advice.